StockCharts TVPublished 2026-09-25
“These Stocks Fell Out of Favor. Now They’re Turning Higher”
$IBBBullish
Biotech sector (IBB) is poised to resume an uptrend following a recent recovery.
Attention should also be paid to biotechnology companies ( IBB), as shares in this group rose by 2.6% . Note the dynamic we saw in mid- August, and much of this rise is due to Moderna's progress in DNA and other areas.
We have seen a remarkable recovery in the group as a whole after its decline, and we are now on the verge of restoring this upward trend. This is another area where we will take a look at some stocks that have declined in popularity and then reappeared.